central and peripheral glp 1 systems independently suppress eating Why does GLP‐1 agonist combined with GIP and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes? - Jiang - 2025 The central and peripheral effects

This renewed vigor is evidenced by a remarkable uptick in the number of registered clinical trials: 2023 alone saw 30 new trials, with 40% of those being industry sponsored (Full list of ongoing clinical trials in the space available here

Protein adequacy often has greater practical impact than isolated micronutrient supplementation

Nadolsky and asked if he was hiring dietitians

Incretins are gastrointestinal hormones that increase glucose-dependent insulin secretion

Dose adjustments happen in response to in-person evaluation, not a questionnaire

These medications do not interfere with thyroid hormone replacement (like levothyroxine or NP Thyroid) and are generally safe for people with autoimmune conditions